LOXL2/3
|
SNAG domain; K98 and K127
|
Notch/Lox
|
[17]
|
NF-κB
|
Promoter: -194 to -78 bp
|
TNFα, RANKL, PI3K/Akt
|
[20],[43],[44]
|
HIF-1α
|
Promoter: -750 to -643 bp
|
Hypoxic conditions
|
[19]
|
SMADs
|
Promoter: -631 to -506 bp
|
TGF-β1, Ras
|
[45],[46]
|
IKKα
|
Promoter: -631 to -506 bp (concurrent with SMADs)
|
TGF-β1, Ras, PI3K/Akt
|
[21],[44],[46]
|
HMGA2
|
Promoter: 2 regions within -131 to -92 bp
|
TGF-β1
|
[22]
|
YY1
|
3’ Enhancer
|
NF-κB
|
[30]
|
Egr-1
|
Promoter: 4 sites between -450 and -50 bp
|
HGF, MAPK
|
[29]
|
PARP-1
|
Promoter: SIRE
|
ILK
|
[23]
|
Gli1
|
There are 4 candidate GLI binding sites (consensus sequence for binding: 5'-GACCACCCA-3')
|
Shh, Wnt
|
[26]
|
STAT3
|
Promoter
|
IL-6/JAK, HB-EGF/EGFR/MEK/ERK (mice)
|
[24],[25]
|
MTA3
|
Promoter
|
ER
|
[27],[28]
|
PAK1
|
S246
|
|
[36]
|
GSK-3β
|
Motif 1 (S96, S100, S104) and Motif 2 (S107, S111, S115, S119)
|
Wnt, PI3K/Akt, FGF
|
[33],[34]
|
Snail1 |
Promoter: E box within SIRE |
Binds to own promoter |
[31] |